Promising patient studies surrounding the medication Retatrutide , specifically the high-dose formulation referred to as ZPHC, suggest a considerable benefit on weight loss and associated metabolic factors. Scientists posit that this innovative compound, influencing both GLP-1 and GIP pathways , has the potential to represent a major improvement i